Menu visibility control

Video

Events

Startup Surgery

Most Recent

News

Top tech hubs in the South West of England

Investments

Smart home security startup Cocoon raises £2.46m on Crowdcube

Guide

IP Law: The Startup & Scaleup Guide

Press Releases

Starling Bank unveils beta as it begins roll out to first customers
VentureFounders surpasses £40m funding mark in 2 years of operation
Software testing leader TestPlant appoints Dr. John Bates as CEO

Oxford BioTherapeutics secures $10m from Silicon Valley Bank

Medical Lab
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Oxford BioTherapeutics has secured a $10m capital term loan from Silicon Valley Bank to accelerate the expansion of its research and development efforts.

OBT is an international clinical stage biotechnology company focused on developing innovative antibody based therapeutics, including antibody-drug conjugates, to treat cancer and other diseases.

OBT uses the optimal combination of technologies in ADC development through its collaborations with leading companies in the field and its novel OGAP target discovery system – one of the largest of its kind in the world – to provide a unique range of validated, novel antigen targets.

Forget Silicon Valley, Europe’s tech clusters can be stronger together

Christian Rohlff, CEO of Oxford BioTherapeutics, said: “This additional financial support will enable Oxford BioTherapeutics to accelerate the development of our medicines.

“With a long history of supporting life science businesses, Silicon Valley Bank is a valuable partner that recognises Oxford BioTherapeutics’ ability to transform the treatment of cancer and other diseases in an innovative way.”

Nooman Haque, director of UK life sciences and healthcare for Silicon Valley Bank, added: “Silicon Valley Bank is working alongside leading UK life science businesses, like Oxford BioTherapeutics, to provide financial solutions that support this sector’s ambitions to bring innovative therapies to the market.

“This financing demonstrates Silicon Valley Bank’s unique ability to work with businesses like Oxford BioTherapeutics by complementing their equity financing to provide an efficient solution to help stimulate their growth.”

The financing will provide $10m in capital, with $5m being funded immediately. The debt will complement new equity the company is raising.

Enter your email address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

Bristol - South West of England

Top tech hubs in the South West of England
posted 10 mins ago

Founding Team Cocoon

Smart home security startup Cocoon raises £2.46m on Crowdcube
posted 3 hours ago

IP Law guide featured image (2)

IP Law: The Startup & Scaleup Guide
posted 6 hours ago

social media

ContentCal closes £400,000 Seed, brings total to £580,000
posted 6 hours ago

BGV A16 cohort photo

Tech for good accelerator Bethnal Green Ventures raises £1.3m to invest in startups
posted 7 hours ago

Tech Nation Newcastle

Tech in Newcastle: Tackling the skills and office shortage
posted 8 hours ago